US Patent 11104663 Ciprofloxacin polymorph and its use
Patent 11104663 was granted and assigned to CritiTech on August, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+111 characters)
Article
Patent abstract
The present disclosure relates to ciprofloxacin polymorphs and their use in treating infections.
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 7 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111046630
Date of Patent
August 31, 2021
0Patent Application Number
201809280
Date Filed
September 28, 2018
0Official Website
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111046630
Date of Patent
August 31, 2021
0Patent Application Number
201809280
Date Filed
September 28, 2018
0Official Website
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 9 Sep, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11104663 Ciprofloxacin polymorph and its use
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11104663
Date of patent
August 31, 2021
Patent application number
20180928
Date Filed
September 28, 2018
Find more entities like US Patent 11104663 Ciprofloxacin polymorph and its use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
